Diseases

The coalition, known as the National Conference of Pharmaceutical Organizations (NCPO), and American Pharmacists Association (APhA) issued a public statement seeking support from the…
Read More...

Clinical-stage pharmaceutical company, Imago BioSciences developing novel therapies for hematological and inflammatory diseases asserted FDA's acceptance of their Investigational New…
Read More...

Allergan plc asserted that the U.S Food and Drug Administration has approved Allergan's  supplemental New Drug Application to augment the use of AVYCAZ (ceftazidime and avibactam) to…
Read More...

Clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, Syndax Pharmaceuticals ventured into new Clinical collaboration with AstraZeneca to…
Read More...

Panacea Pharmaceuticals, a clinical stage bio-pharmaceutical company developing novel biologically--targeted cancer therapies and diagnostics declared the enrollment of patient in an…
Read More...

Yunnan Fuwai Hospital declares successful completion of clinical case of MitralStitch mitral valve repair system. The operation was jointly conducted by the team of Professor Pan…
Read More...

It is noteworthy that TVA Medical's everlinQ endoAVF System exhibited positive Clinical results using the everlinQ endoAVF System. An international meta-analysis of clinical experience…
Read More...

Ambry Genetics and Invicro partner to offer customized genomics and imaging services for the pharmaceutical and biotechnology industry, exhibiting profound emphasis on Oncology and…
Read More...

FDA permits a Phase II Clinical Trial in 60 stroke patients, NuvOx Pharma announced FDA approval to proceed to test its investigational drug product, dodecafluoropentane emulsion…
Read More...

Developer of novel surgical tools to enhance a surgeon's ability to perform minimally invasive orthopedic procedures, Ceterix Orthopedics declared completion of enrollment in STITCH…
Read More...

Hisamitsu Pharmaceutical in collaboration with U.S subsidiary, Novel Pharmaceuticals, Inc declares that the the transdermal patch for the treatment of schizophrenia Development code:…
Read More...

Phase II ‘basket’ clinical trial of PB272 (neratinib) in patients with tumors harboring HER2 or HER3 mutations results were declared by Puma Biotechnology as published in the journal…
Read More...

Vertex Pharmaceuticals selected VX-659 and VX-445 for Phase 3 development as part of two different triple combination regimens fir people with cystic fibrosis. Phase 2 data was…
Read More...

Ferring Pharmaceuticals affirmed that the U.S FDA has sanctioned ZOMACTON for injection 5 mg and 10 mg recombinant human growth hormone implied for replacement of GH in adults with GH…
Read More...

Global provider of cloud-based technology and data analytics for clinical research, Medidata and Syapse partner to transform Oncology Clinical Trials for the age of precision medicine.…
Read More...

SkylineDX affirmed foraying into a strategic collaboration to curate novel diagnostic tests to enhance clinical decision making for melanoma patients. The Joint development agreement…
Read More...

Novartis declared results from ELIANA Clinical Trial of kymriah in refractory pediatric and young adult patients with B-cell acute lymphoblastic leukemia.  Kymriah claimed to become one…
Read More...

Perrigo Company declared having sought tentative U.S FDA approval for the generic version of Soolantra cream,1%. Soolantra cream implied for the treatment of inflammatory lesions of…
Read More...

Microbiome comapany developing customized phage therapies , BiomX Ltd. declared that it has sought sub-license from JSR Corporation a set of bacterial targets for the development and…
Read More...

Clinical-stage biotechnology company,devoted to treating inflammation and inborn errors of metabolism, Aldeyra Therapeutics enrolled first patient in a Phase 2b Clinical Trial of …
Read More...